chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Began just as sudden sharp headache on 12/21/20 at 6:00 pm, noticed after shift after showering, left upper extremity was slightly red,  and slightly tender to touch. Not unbearable. 12/22/20 noticed redness was continuing to spread and arm was beginning to ache, still not unbearable. On 12/23/20 during shift, the redness in my left upper arm had spread from elbow to below injection site, arm was increasingly aching as well as new noticeable left sided facial swelling from directly underneath the left eye throughout the cheek area. and slightly tender. This is when I checked into the urgent care and was examined.  At first the mid-level reported she thought I had experienced vaccine induced bellspalsey; however, after consulting with the MD,  this was dismissed. Left upper extremity was diagnosed as cellulitis and treated with bactrim and informed to take zyrtec or benadryl for facial swelling. If symptoms worsened, visit nearest ER. Also informed to report symptoms to CDC for tracking. Today I have been treated with 2 full days of antibiotics and the redness and swelling has reduced. left sided facial swelling remains present.
My left eye lid became swollen the next day after both of my Pfizer vaccines, gave me flank pain and raised my blood sugars. Also I currently still have eye pain behind both of my eyes.
Fever of 103.5 for two days even with IBU & APAP. After two days decreased to about 100. Significant aches. Nausea, vomiting, diarrhea. Patient reports symptoms lasted about five days.
A couple of weeks after my second shot I started shedding a lot of hair and I'm still having that. I also had the usual stuff like fever. No medical care sought, and this is still ongoing.
ears hurt, neck is yellow, has rash, had fever for 3 days (103) now gone, is achey, can't swallow @ noc; Pt seen @ ER on 29APR93;
This spontaneous report as received from a nurse practitioner refers to approximately 10 unspecified patients. On an unknown date, the patients were vaccinated with approximately 10 doses of PROQUAD (Merck) (Lot # reported as H015785, expiration date 24-FEB-2014 and lot # reported as J00432, expiration date 17-OCT-2014) and VARIVAX (Merck) (Lot # reported as J003532, expiration date 25-MAR-2015) that were exposed to -4C for 720 hours (30 days) which was not supported. No adverse effects were reported. Additional information has been requested.
Normal labor and delivery on 6/25/2021. Hospital admission within 6 weeks of receiving the COVID vaccine.
pain at the injection site; swelling at inhection site; drained all of her mom's energy; lifeless; unable to lift her arm; This spontaneous report was received from a consumer concerning her mother, an 85 years old female patient. The patient's current conditions included penicillin allergy and sulfur allergy. No medical history or concomitant therapy was reported.   On 16-OCT-2021, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (dose, route and lot# were not reported) as prophylaxis.  On 17-OCT-2021 (reported as a day after the vaccine), the patient had severe pain and swelling at the injection site (vaccination site pain and vaccination site swelling). The patient was also unable to lift her arm (movement disorder) and had to sleep in a recliner because she was unable to lay on her arm. The reporter reported the vaccine drained all of her mom's energy (asthenia) and the patient was lifeless (feeling abnormal). The reporter spoke to her mother's physician and was told to ice the arm. No lab test was performed. On 09-NOV-2021, all the events were resolved. Action taken with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not applicable.   The causality between the events and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was related as it was noted all the events were reaction to the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23).
It  was reported that a patient (1 of 2) received a Fluzone SV '00-'01 vaccination. Sometime after the injection the patient complained of induration, swelling and redness and injection site. Further information is requested.
Patient reported on 1/19/21:  I received the second dose of the Phizer Covid vaccine on 1/11/2021 in my left arm. Immediately after the injection my arm felt weak to the point I was unable to lift it for 2 days. Currently I can move my arm but it continues to feel weak.
Discharge Provider: MD Primary Care Provider: MD Admission Date: 2/8/2023 Discharge Date: 02/12/2023  PRESENTING PROBLEM: Acute blood loss anemia [D62] Weakness [R53.1] Acute weakness [R53.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE:   Patient is aa 72F with PMH of CVA 2022 s/p L MCA thrombectomy w/ r sided def,exp aphas/dysarthia, HTN, GI bleed hx AV malformations s/p cautery ,hypothyroid, OSA on CPAP, DMII, Von Willebrand, HCC 2/2022 s/p SPRT with response, pAfib on Eliquis 2.5 s/p amplatz amulet that thrombosed -> eliquis, HF EF 65%, dysphagia who presents with generalized weakness due to COVID 19. For 2-3 days patient had worsening weakness and couldn't get out of bed day before admission and was found to have COVID. Felt horrible but vitals were stable and on room air. Neuro exam stable. Bumex held due to intravascular depletion.  Patient missed TEE to look at thrombosed heart device that causes stroke. Cards said outpatient TEE and follow up can be done. Heme onc c/s who recommended continueing home regiment. 2/10 patient has wrosening tachycardia and shortness of breath. Bumex was initially held due to dryness and restarted with good UOP. CXR showed some consolidation concerning for pneumonia vs. Edema, with good response and improvement of her symptoms after resuming home Bumex.   On the day of discharge she was evaluated by occupational therapy and physical therapy and did not have any documented desaturations in completed 5 days therapy of remdesivir.  Noted to have potassium of 3.0 on the day of discharge which was supplemented (and home potassium supplement resumed) and recommended to follow up with PCP in the next 5-7 days with recheck of her electrolytes and renal function.
No immediate allergic reaction, however that evening (and continuing through to today - now almost 2 weeks later) my hands have been covered in red hives and have been extremely itchy. It burns under water and when heat is applied. The hives started on the back of my hand and now have spread to the tips of my fingers. As I am breastfeeding an 8 -month old, I have not taken Antihistamines nor NSAIDS for relief. I have had no fever nor pain in my arm since the vaccine, however these hives have become severely debilitating.
Covid pfizer ages 5-11 (orange CAP) 0.3 ML undiluted was administered. Patient denies symptoms.
Head ache and vomiting within a few hours following vaccine administration. Client had a fever and had a racing pulse the evening following vaccine administration.
moderate pain in left arm following first injection; This is a spontaneous report from the contactable nurses.  An 86-year-old male patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE), intramuscular administered on arm left on 03Mar2021 11:00 (Batch/Lot Number: EN6206) as 1ST DOSE, SINGLE for COVID-19 immunization at the urgent care facility.  Ongoing medical history included cerebrovascular disease, dementia, essential hypertension, type II diabetes mellitus (DM), constipation and pain. Concomitant medications included senna acutifolia (SENNA ACUTIFOLIA) taken for constipation from an unspecified start date and ongoing; acetylsalicylic acid [ASPIRIN (E.C.)] taken for cerebrovascular accident (also reported as decrease stroke risk) from an unspecified start date and ongoing; glimepiride (GLIMEPIRIDE) taken for type 2 diabetes mellitus from an unspecified start date and ongoing; ibuprofen (IBUPROFEN) taken for pain from an unspecified start date and ongoing; and losartan (LOSARTAN), amlodipine (AMLODIPINE), and metoprolol succinate (METOPROLOL SUCCINATE) all three taken for blood pressure/essential hypertension from unknown dates. On 03Mar2021 11:00, the patient had moderate pain in left arm following first injection. The event was considered as serious (life threatening and persistent/ significant disability/ incapacity). Outcome of the event was not recovered.; Sender's Comments: Based on the compatible temporal association, there was a reasonable possibility that the vaccination with BNT162B2 played a contributory role in triggering the onset of the reported vaccination site pain.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to  Committees and Investigators, as appropriate.
Second dose of vaccine was inadvertently given 2 weeks after first dose was given on 2/2/21
Information has been received from a registered nurse concerning a 19 year old female who on 17-JUN-2008 was vaccinated with a first dose of GARDASIL vaccine (yeast) by intramuscular injection (lot number, injection site not reported) and a dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (manufacture unknown). Subsequently the patient experienced faint. Additional information has been requested.
A week after the shot, I developed a red ring around the injection site. Some tenderness and itchiness. For the first 3 or 4 days, I did feel some pinpricks at the injection site, but I don't anymore.
Patient reported shaking violently, lost control, shivers that caused teeth to chatter. Patient took 2 tablets of acetaminophen 325mg tablets and turn up the heat. Stated he started to feel better 3 hours later
Information has been received from a healthcare worker (medical assistant) referring to unspecified patients of unknown age and gender. No pertinent medical history or drug reaction/allergies was reported. On unknown dates since 07-MAY-2015 the patients were vaccinated with VARIVAX (Merck) (lot# L006386, expired date 25-FEB-2017; lot# L000454, expired date 06-JAN-2017, lot# K020760, expired date 31-OCT-2016; lot# K016128, expired date 23-SEP-2016). These vaccines were exposed to temperatures outside of the recommended range. No adverse experience had been reported. This is one of two reports received from the same reporter. Additional information has been requested.
Severe body shaking and delirium for about 8 hours, Intense general muscle and joint pain, with splitting headache continuing after 36 hours. Inability to mentally focus
felt absolutely miserable; Initial information received on 20-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional via social media.  This case involve patient (unknown demographics) who experienced felt absolutely miserable, when received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer lot number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious felt absolutely miserable (feeling abnormal) (unknown latency) following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.   It was not reported if the patient received a corrective treatment.  The event outcome was unknown for feeling abnormal.  There will be no information available on the batch number for this case.
Pt was in good health until he reported to the Clinic on 06 Feb 08 for evaluation of abdominal pain.  His pain started approx 01 Feb and persisted for a total of 6-7 days.  Lab review at that time noted elevated eosinophils.  He subsequently underwent a thorough evaluation by Infectious Disease on 25 Feb, Cardiology on 27 Feb, Hematology on 29 Feb, and Allergy on 28 Mar.  These evaluations and subsequent diagnostics did not identify an etiology for the eosinophilia.  F/U with ID on 31 Mar noted that other than occas headaches, he has returned to his normal health.  DX: Eosinophilia  Symptom: Abdominal Pain Start: 02/01/2008 End: 02/06/2008
developed COVID symptoms/after getting the first dose, the patient tested positive for COVID; developed COVID symptoms/after getting the first dose, the patient tested positive for COVID; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a male patient of an unspecified age received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that after getting the first dose, the patient tested positive for COVID. The patient developed COVID symptoms on an unspecified date (reported as 11 days ago). During the day of the report, it was day 10 of having symptoms of COVID and being quarantined. The day after the report will be day 11 (as reported) and he has no lingering symptoms and feels fine and CDC says you are clear after 10 days. He is currently symptom free and wants to knows if he is eligible to receive the second dose. The outcome of the events was unknown. The events were reported as non-serious.   Information about lot/batch number has been requested.
every time she takes a shot she does the same thing/ start her period; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP), Program ID.  An adult female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MENSTRUAL DISORDER (non-serious), outcome "unknown", described as "every time she takes a shot she does the same thing/ start her period".  Additional information: It was reported that other women have the same problem. she knows someone the same age. States it happened last year she thinks she was 56. Caller proceeds to state she talked to another girl every time she takes a shot she does the same thing, she started hers too and she is the same age. She has talked to several other people and they have the same thing.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201139735 same reporter/product/event, different patient;
Severe pain in left armpit, especially when reaching down to grasp.  It is painful to the touch. Also, right hip stiffness and pain.
returned of her TMJ; headaches described as a migraine; difficulty walking; could not move her legs; lose her balance; upset stomach; This case was reported by a consumer via call center representative and described the occurrence of walking difficulty in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included temporomandibular joint disorder. Previously administered products included Shingrix with an associated reaction of no adverse event (received 1st dose on an unknown date and had no issues). Concurrent medical conditions included multiple sclerosis, rheumatoid arthritis and overactive bladder. Concomitant products included flavoxate.   On 21st February 2022, the patient received the 2nd dose of Shingrix (intramuscular) 50 µg. In February 2022, 24 hrs after receiving Shingrix, the patient experienced walking difficulty, movement disorder, loss of balance and upset stomach. On 13th March 2022, the patient experienced migraine. On an unknown date, the patient experienced temporomandibular joint disorder. On an unknown date, the outcome of the walking difficulty, movement disorder, loss of balance and upset stomach were recovered/resolved and the outcome of the migraine was not recovered/not resolved and the outcome of the temporomandibular joint disorder was unknown.   It was unknown if the reporter considered the walking difficulty, movement disorder, loss of balance, upset stomach, migraine and temporomandibular joint disorder to be related to Shingrix.     Linked case(s) involving the same patient:  US2022AMR050421  Additional details were provided as follows:  The patient self-reported this case.   The patient had current medication history of multiple sclerosis, rheumatoid arthritis, and overactive bladder prior to her Shingrix vaccination.                                   The patient received her 2nd dose of Shingrix into the muscle of her left arm and 24 hours after, she had difficulty walking, could not move her legs, and would lose her balance.  The patient also experienced upset stomach.  These symptoms all resolved after 24 hours.  However, over that past few weeks, the patient reported having headaches and the return of her TMJ. She described her headache as a migraine which started last Sunday. The patient discontinued her Flavoxate prescription which she had been taking since 2016 for her overactive bladder, in case that was contributing to her headache.  Her headache had still not resolved but the patient stated she no longer had any overactive bladder symptoms. Patient had no issues with the 1st dose of Shingrix. The reporter could not provide the lot number or expiration of the vaccine given.  The reporter gave consent to contact health care professional (HCP).   The reporter consented to follow up. This case was linked with case US2022AMR050421, reported same reporter for same patient.
Two days after giving birth to my son via caesarean I was given 2 vaccines and informed that I needed them and it would help protect my baby. I was not informed by the hospital of the possible side effects or risks to my newborn, who I was breast feeding, or myself. I was not released from the hospital until later that day and by then I was already starting to feel like I was coming down with the flu. By the next day my all of my joints were in excruciating pain, I had body aches, and my wrists were so stiff I couldn't pick up my baby. I was sleeping under 3 comforters and have never been more tired in my entire life. What was so odd is I didn't run a fever so I know I didn't have the flu. This went on for 2 weeks. I seriously thought I was going to die. My baby has always had trouble sleeping most nights, has had the flu, an ear ache, and had to undergo breathing treatments all in his first 4 months of life.  No one that has just given birth should ever be given a vaccine of any kind! The body is so weak and stressed from the birth already and when there are viruse vaccinations on top of that is deadly for mother and child. I am a super health and fit person too. These vaccines were pushed on to a scared new mother trying to do what best for her baby and self but this could have killed us both!
patient that was given MENACTRA, 1st dose at age 11 and 2nd dose at age 12. He is also asking if a booster dose should be given at 16 with no reported adverse event; Initial information received on 12-Oct-2022 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a 12 years old and unknown gender patient who experienced patient that was given MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA], 1st dose at age 11 and 2nd dose at age 12. he is also asking if a booster dose should be given at 16 with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided.   On an unknown date, the patient received a 1 dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE at an unknown dose (lot number, expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination. On an unknown fate, the patient received 2nd of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  On an unknown date the patient given menactra, 1st dose at age 11 and 2nd dose at age 12. he is also asking if a booster dose should be given at 16 with no reported adverse event (inappropriate schedule of product administration) (same day latency) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  Action taken: Not applicable.  Outcome: Unknown.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Nausea began approx. 3 hours after the vaccine was given. Later that night around 10 hours post-vaccine the joints in my hands began to ache severely (like arthritis). The next day the nausea became extremely severe, and approx. 36 hours after vaccination I developed hives on my eyelids.
Pt recvd 2 dose of Engerix-B following 2nd dose exp high fever, h/a, nausea, vomiting, & diarrhea;
Temp 99.2, body aches, (R) arm soreness, headache, fatigue.
unrelated issue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (unrelated issue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (unrelated issue). At the time of the report, VACCINATION COMPLICATION (unrelated issue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  No treatment medication were reported.
This spontaneous report as received from a registered pharmacist refers to a patient of unknown age. The patient's medical history included shingles. In "late summer/early fall" of 2013, the patient was vaccinated with ZOSTAVAX (dose, route and lot # not reported). The pharmacist reported that 1 week after vaccination, the patient experienced a mild case of shingles. The outcome of shingles was unknown. Additional information has been requested.
fever 103.0 24AUG95, 25AUG95 ached all over; numbness fingers, cheeks, toes & 1SEP95 back to school fine today;
PT RECEIVED FLU MIST, MENINGITIS, TDAP, AND HPV VACCINES ON 12/05/08.  ON 12/10/08 DEVELOPED FEVER, STOMACHACHE AND WENT TO EMER RM.  PREGNANCY DIAGNOSED @ 8-12 WKS GESTATION.  LMP WAS 30 DAYS PRIOR TO VACCINATIONS.